CSRC offers members pre-competitive collaboration with cardiac safety professionals on vital research topics and projects. Working together, we have the opportunity to accomplish public health objectives that no single stakeholder could achieve on its own.
Who are CSRC members?
CSRC is a multi-stakeholder consortium comprised of:
- U.S. and international regulatory bodies
- Pharmaceutical, biotech, medtech, and medical device companies
- Scientific research associations
- Medical professional organizations
- Non-governmental organizations (NGOs)
- Academic institutions
- Individuals with a background and strong interest in cardiac safety as it relates to research, medicine and/or public health
CSRC member organizations are invited to designate representatives to participate in CSRC initiatives. Representatives should have extensive experience in cardiac safety and a deep interest in advancing cardiac safety research. People who participate in CSRC are typically motivated to collaborate professionally in a multi-stakeholder environment on current cardiac safety issues with the goal of positively impacting pressing public health issues.
What are the benefits of joining CSRC?
- Interact directly with fellow CSRC members from the U.S. FDA and international regulatory bodies concerning areas related to drug and device development and cardiac safety
- Enjoy preferred access to CSRC think tanks and multi-stakeholder panel discussions for real-time insight on emerging issues
- Receive an exclusive invitation to the CSRC annual meeting where the latest developments in cardiology will be addressed by leading experts from the worlds of academia, industry, and government
- Drive strategic direction of CSRC and scientific focus where it is most needed through corporate representation on Scientific Advisory Committees
- Network with industry thought leaders and corporate influencers to advance cardiac safety initiatives
- Collaborate, as part of multi-stakeholder therapeutic area committees, to address specific areas of cardiac safety, including but not limited to cardiogenic shock, cardio-oncology, heart failure, proarrhythmia, etc.
- Create and participate in think tanks to influence development of best practices and advance regulatory science on emerging issues in cardiac safety
- Contribute as authors on peer reviewed CSRC publications and white papers in areas of interest to the cardiology community
- Leverage professional network of national and international experts to find answers to real-time questions, access interactive webinars, and elicit feedback on work projects
- Access enduring publications and data warehouse of information on www.cardiac-safety.org
- Participate in the CSRC online Member Resource Network of speakers, researchers, and industry scientists
- Represent CSRC at functions and in public forums/communications materials
- Access to CSRC’s quarterly e-newsletter CSRC Connection
Contact us at email@example.com to learn more about available membership options.
“If you want to go fast, go alone. If you want to go far, go together.”African Proverb
What CSRC Members are Saying
- ACI Clinical
- AstraZeneca International
- AtCor Medical
- Bayer Healthcare Pharmaceuticals
- Biomedical Systems
- BioTelemetry Research
- Boehringer Ingelheim
- Bristol Myers Squibb
- Cardiovascular Systems Inc. (CSI)
- CSL Behring
- dabl, Ltd.
- Duck Flats Pharma
- Duke University
- Eli Lilly and Company
- Global Instrumentation
- High Point Clinical Trials Center
- InvivoSciences, Inc.
- Johnson & Johnson
- Merck & Co., Inc.
- OBS Medical
- PAREXEL Informatics
- Pfizer, Inc.
- Regeneron Pharmaceuticals
- Richmond Research Institute
- Salix Pharmaceutical
- Taylor Microtechnology
- Vince and Associates Clinical Research
- VistaGen Therapeutics
- WCCT Global
- Welch Allyn